It should be highlighted that gp60 allows albumin to participate in the specific targeting of cancerous cells because it mediates the transportation of medicines in albumin-based drug delivery systems via biological, epithelial, and endothelial barriers, undergoing overexpression in cancer cells [33]. This evidence concerns the gene ALB and cancer.